Evidence map›Paper›PMID 41323682›Full record

ArticleFood chemistry: X2025

Phytoconstituents, antioxidant and enzyme inhibition activities of coffee beans through widely targeted metabolomes and

Yuan Wang, Zizheng Huang, Hongyan He, Xiandong Zhou, Dingshan Yang, Peng Shu, Xueqing Chen, Jinhuan Cheng, Yao Ma

Abstract read
In one paragraph

Article in Food chemistry: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuan WangHBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd., Shenzhen 518000, China.
Zizheng HuangSchool of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
Hongyan HeYunnan Academy of Agriculture Engineering, Kunming 650200, China.
Xiandong ZhouHBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd., Shenzhen 518000, China.
Dingshan YangHBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd., Shenzhen 518000, China.
Peng ShuHBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd., Shenzhen 518000, China.
Xueqing ChenHBN Research Institute and Biological Laboratory, Shenzhen Hujia Technology Co., Ltd., Shenzhen 518000, China.
Jinhuan ChengYunnan Academy of Agriculture Engineering, Kunming 650200, China.
Yao MaSchool of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coffee has transcended from a beverage into a functional food, with its efficacy heavily influenced by germplasm diversity. We systematically analyzed 37 coffee accessions, revealing substantial diversity in morphological characteristics, crude extract yield, antioxidant capacity, and enzyme inhibition. Widely targeted metabolomics on three accessions exhibiting distinct bioactivities identified 2,933 compounds. The predominant classes, with representative metabolites, include 404 terpenoids (e.g., cafestol and kahweol), 362 flavonoids (e.g., tangeretin and rutin), and 340 phenolic acids (e.g., chlorogenate and cryptochlorogenic acid). Flavonoids and organic acids were the main differential metabolites across the three accessions and were enriched in relevant metabolic pathways. K-means and correlation analysis confirmed that flavonoids and organic acids, particularly syringetin-3-O-glucoside and chlorogenic acid, were key bioactivity drivers. Our study constructs a comprehensive metabolite and bioactive database for the rational selection of coffee accessions in the development of functional foods, dietary supplements, and cosmeceuticals with targeted health benefits.

Indexed as

BioactivityChemometricsCoffeeMetabolomicsPotential bioactive compounds

Identifiers

PMID41323682
PMCPMC12657746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.